MN

Manjeet Nath Mishra

Active Director Director DIN 06796474
DIN 06796474 First appointment Feb 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Feb 2014
Shareholding value •••• Premium profile

About Manjeet Nath Mishra

Data last updated:

Manjeet Nath Mishra is a Director at Msr Pharmaceuticals Private Limited (since 2014), Director at Shivakam Healthcare Private Limited (since 2023) and Director at Shivakam Pharmaceuticals Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Paper and Infrastructure and Utilities. The 2 current companies with reported revenue have a combined latest revenue of ₹5.27 Cr; the largest is Msr Pharmaceuticals Private Limited at ₹4.11 Cr (FY 2025). Earlier, Manjeet Nath Mishra was a Director at Eurokem Pharmaceuticals Private Limited (2021–2023).

DIN 06796474
Primary Designation Director
Industry Pharma
First Appointment 08 Feb 2014
Oldest Company Age 12 yrs
Largest company Msr Pharmaceuticals Private Limited · ₹4.11 Cr (FY 2025)
Combined revenue ₹5.27 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Msr Pharmaceuticals Private Limited U74120BR2014PTC022014
Director08 Feb 20142014₹4.11 Cr (FY 2025)Active
Shivakam Healthcare Private Limited U21001HP2023PTC009989
Director06 Apr 20232023₹1.16 Cr (FY 2025)Active
Director03 Jul 20252025Active
Director22 Feb 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jul 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aahana Developers And Buildings Private Limited
Msr Pharmaceuticals Private Limited
Shivakam Healthcare Private Limited
Shivakam Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manjeet Nath Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjeet Nath Mishra

Manjeet Nath Mishra currently holds 4 directorships: Msr Pharmaceuticals Private Limited (Director, since 08 Feb 2014, revenue ₹4.11 Cr (FY 2025)); Shivakam Healthcare Private Limited (Director, since 06 Apr 2023, revenue ₹1.16 Cr (FY 2025)); Shivakam Pharmaceuticals Private Limited (Director, since 03 Jul 2025); Aahana Developers And Buildings Private Limited (Director, since 22 Feb 2016).

Manjeet Nath Mishra was first appointed on 08 Feb 2014 as Director at Msr Pharmaceuticals Private Limited. The most recent appointment on record is 03 Jul 2025 at Shivakam Pharmaceuticals Private Limited.

The 2 current companies of Manjeet Nath Mishra that report revenue have a combined latest revenue of ₹5.27 Cr: Msr Pharmaceuticals Private Limited ₹4.11 Cr (FY 2025); Shivakam Healthcare Private Limited ₹1.16 Cr (FY 2025).

Manjeet Nath Mishra held 1 earlier board appointment: Eurokem Pharmaceuticals Private Limited (Director, 23 Jul 2021 to 25 Feb 2023).

The current boards of Manjeet Nath Mishra's companies include Praveen Kumar Singh (Msr Pharmaceuticals Private Limited), Amit Kumar Mishra (Shivakam Healthcare Private Limited), Khushboo Kumari (Shivakam Pharmaceuticals Private Limited), Shilpi Chauhan (Shivakam Pharmaceuticals Private Limited), Vikash Kumar (Shivakam Pharmaceuticals Private Limited), Shweta Bharti (Aahana Developers And Buildings Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available